Table 4.
Correlation between Vitamin D and selected parameters according to COVID-19 and gender status.
| Parameters | Control | Case | ||||||
|---|---|---|---|---|---|---|---|---|
| Female | Male | Female | Male | |||||
| R | p-Value | R | p-Value | R | p-Value | R | p-Value | |
| Age (years) | 0.48 ** | 0.00 | −0.13 | 0.44 | 0.09 | 0.54 | 0.19 | 0.12 |
| BMI (kg/m2) | 0.15 | 0.37 | −0.04 | 0.83 | 0.03 | 0.82 | 0.01 | 0.94 |
| WHR | 0.18 | 0.30 | 0.02 | 0.92 | 0.03 | 0.89 | 0.09 | 0.60 |
| Systolic BP (mmHg) | 0.14 | 0.41 | 0.04 | 0.82 | 0.03 | 0.84 | 0.20 | 0.10 |
| Diastolic BP (mmHg) | −0.06 | 0.74 | 0.24 | 0.15 | −0.02 | 0.92 | −0.09 | 0.46 |
| Temperature (°C) | 0.11 | 0.52 | 0.07 | 0.71 | 0.07 | 0.65 | −0.03 | 0.81 |
| Pulse rate | 0.20 | 0.22 | 0.29 | 0.11 | 0.13 | 0.36 | −0.07 | 0.57 |
| Respiratory rate | −0.01 | 0.96 | −0.10 | 0.64 | 0.55 ** | 0.00 | 0.19 | 0.12 |
| Growth factors | ||||||||
| EGF (ng/mL) | −0.19 | 0.25 | −0.12 | 0.49 | −0.30 | 0.19 | 0.39 * | 0.05 |
| F-GF2 (pg/mL) | −0.29 | 0.08 | 0.05 | 0.78 | 0.28 | 0.31 | −0.05 | 0.81 |
| TFGα (ng/mL) | −0.04 | 0.80 | 0.01 | 0.96 | 0.09 | 0.71 | 0.20 | 0.30 |
| VEGF (ng/mL) | −0.10 | 0.58 | 0.62 ** | 0.00 | 0.15 | 0.52 | 0.11 | 0.64 |
| Colony Stimulating Factors | ||||||||
| G-CSF (pg/mL) | −0.09 | 0.64 | 0.13 | 0.52 | −0.01 | 0.96 | −0.34 | 0.14 |
| GM-CSF (pg/mL) | −0.17 | 0.32 | −0.09 | 0.62 | 0.14 | 0.65 | −0.13 | 0.55 |
| Interleukins | ||||||||
| IL-1ra (pg/mL) | −0.16 | 0.46 | 0.08 | 0.73 | 0.15 | 0.62 | 0.01 | 0.97 |
| IL-1α (pg/mL) | −0.05 | 0.84 | 0.25 | 0.43 | 0.33 | 0.42 | 0.50 | 0.07 |
| IL-1β (pg/mL) | −0.07 | 0.75 | 0.08 | 0.74 | −0.33 | 0.23 | −0.02 | 0.94 |
| IL-2 (pg/mL) | −0.13 | 0.49 | 0.10 | 0.59 | −0.50 | 0.06 | 0.08 | 0.75 |
| IL-4 (pg/mL) | −0.19 | 0.26 | −0.12 | 0.48 | 0.05 | 0.84 | 0.34 | 0.09 |
| IL-5 (pg/mL) | −0.06 | 0.73 | 0.14 | 0.42 | 0.05 | 0.82 | 0.15 | 0.46 |
| IL-6 (pg/mL) | 0.00 | 0.99 | 0.14 | 0.42 | −0.23 | 0.27 | 0.14 | 0.49 |
| IL-7 (pg/mL) | −0.16 | 0.33 | −0.10 | 0.61 | 0.20 | 0.41 | 0.19 | 0.39 |
| IL-8 (pg/mL) | 0.21 | 0.20 | −0.19 | 0.27 | 0.06 | 0.80 | 0.13 | 0.52 |
| IL-10 (pg/mL) | 0.07 | 0.68 | 0.00 | 1.00 | 0.19 | 0.39 | 0.22 | 0.26 |
| IL-13 (pg/mL) | 0.17 | 0.29 | 0.07 | 0.71 | −0.07 | 0.73 | 0.19 | 0.34 |
| IL-15 (pg/mL) | 0.02 | 0.91 | 0.30 | 0.20 | −0.23 | 0.37 | 0.39 * | 0.04 |
| IL-17α (pg/mL) | −0.05 | 0.75 | −0.25 | 0.14 | −0.36 | 0.06 | 0.10 | 0.63 |
| IL-23 (pg/mL) | −0.08 | 0.63 | 0.01 | 0.94 | 0.03 | 0.87 | 0.19 | 0.33 |
| Chemokines | ||||||||
| EOTAXIN (pg/mL) | −0.20 | 0.22 | −0.04 | 0.80 | 0.05 | 0.84 | 0.06 | 0.78 |
| Fractalkine (pg/mL) | −0.18 | 0.31 | 0.14 | 0.48 | 0.01 | 0.96 | −0.08 | 0.75 |
| GRO (ng/mL) | 0.08 | 0.66 | −0.60 ** | 0.00 | 0.39 | 0.15 | 0.16 | 0.54 |
| IP-10 (ng/mL) | 0.36 * | 0.03 | −0.05 | 0.79 | −0.10 | 0.69 | 0.04 | 0.84 |
| MCP-3 (pg/mL) | −0.32 | 0.09 | −0.06 | 0.79 | −0.05 | 0.89 | 0.23 | 0.46 |
| MDC (ng/mL) | −0.16 | 0.35 | −0.11 | 0.53 | 0.13 | 0.59 | −0.27 | 0.18 |
| MCP-1 (ng/mL) | 0.01 | 0.97 | 0.22 | 0.20 | −0.19 | 0.42 | −0.25 | 0.22 |
| MIP-1α (pg/mL) | −0.21 | 0.24 | 0.12 | 0.52 | −0.29 | 0.26 | 0.37 | 0.07 |
| MIP-1β (pg/mL) | −0.10 | 0.54 | 0.13 | 0.46 | −0.11 | 0.67 | −0.14 | 0.51 |
| Interferons | ||||||||
| IFNγ (pg/mL) | 0.07 | 0.69 | −0.18 | 0.31 | −0.11 | 0.61 | 0.33 | 0.06 |
| IFNα2 (pg/mL) | −0.23 | 0.20 | 0.08 | 0.67 | −0.20 | 0.52 | −0.24 | 0.33 |
| Inflammatory Cytokines | ||||||||
| sCD40L (pg/mL) | −0.01 | 0.95 | 0.06 | 0.72 | −0.34 | 0.14 | −0.17 | 0.40 |
| TNFα (pg/mL) | −0.01 | 0.94 | 0.18 | 0.28 | −0.16 | 0.45 | 0.16 | 0.40 |
| Inflammatory Proteins | ||||||||
| CRP (ug/mL) | 0.14 | 0.41 | 0.19 | 0.27 | −0.51* | 0.04 | 0.12 | 0.57 |
Note: Data are presented as Spearman correlations. * p < 0.01, ** p < 0.05